1.36
Werewolf Therapeutics Inc Borsa (HOWL) Ultime notizie
What analysts say about Werewolf Therapeutics Inc. stockHigh-octane gains - PrintWeekIndia
Is Werewolf Therapeutics Inc. stock a growth or value playHigh-octane financial growth - jammulinksnews.com
Why Werewolf Therapeutics Inc. stock is on top investor watchlistsHigh-profit capital plays - jammulinksnews.com
Is Werewolf Therapeutics Inc. stock overhyped or has real potentialMarket-leading growth rates - jammulinksnews.com
What drives Werewolf Therapeutics Inc. stock priceSky-high return potential - Autocar Professional
Is Werewolf Therapeutics Inc. a good long term investmentRapidly growing investment returns - Autocar Professional
Werewolf Therapeutics Inc. Stock Analysis and ForecastSuperior stock selection - jammulinksnews.com
How Werewolf Therapeutics Inc. stock performs during market volatilityFree Stock Trading Community - Newser
Why Werewolf Therapeutics Inc. stock attracts strong analyst attentionHigh Potential Shares - Newser
What makes Werewolf Therapeutics Inc. stock price move sharplyInvestor Favorite Picks - Newser
Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know - MSN
Vontobel Holding Ltd. Acquires New Stake in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Werewolf Therapeutics to Present Innovative IL-2 INDUKINE Development at KidneyCAN 7th Annual Kidney Cancer Research Summit - Nasdaq
Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit - GlobeNewswire
Werewolf Therapeutics: A High-Risk, High-Potential Bet in Cancer Immunotherapy - criticalcontrolroomworld.com
Werewolf Therapeutics (NASDAQ:HOWL) Trading Up 1% – What’s Next? - Defense World
Werewolf Therapeutics Adopts New Bylaws and Elects Directors - TipRanks
Two Sigma Investments LP Sells 87,168 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Werewolf Therapeutics to Participate in the BIO International Convention - GlobeNewswire
Jane Street Group LLC Acquires 39,564 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Two Sigma Advisers LP Sells 117,200 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):